| About the author |
| Acomplia is an anti- obesity oral prescription drug with Rimonabant as its chief constituent. | |
|
|
|
| Articles written by this author |
|
|
| (Published: Thu, 14 Jun 2007 05:03:08 -0500) |
| Rimonabant (Acomplia/Zimulti) Weight Loss Drug |
| Rimonabant (Acomplia), the new age weight loss drug is developed by world's third largest French pharmaceutical Sanofi-Aventis, to help ever growing number of obese population across the world. Rimonabant is sold under brand name of Acomp |
| Directory: Weight Loss |
|
| |
|
|
